June 20-25, 2010 • Honolulu, Hawai’i
89
islh 2013 • MAY 10-12
FRIDAY CORPORATE LUNCHEONS
SYSMEX
Shaping the Future of Hematology
Friday, May 10, 2013 | 12:00PM - 1:45PM
Dominion North
Program Overview:
In today’s changing healthcare environment, there is
increasing pressure to justify cost, provide more for less and
to improve the quality of healthcare and therapy decisions.
The development of immature cell indices that can provide
useful information about the pathophysiologic mechanism
of hematopoiesis to the clinican to help guide and justify
treatment decisions is becoming more important. This year’s
event will be focused on the clinical utility of two immature cell
indices, the automated Immature Granulocyte Count and the
Immature Platelet Fraction.
The Sysmex Immature Granulocyte Marker: Reference
Ranges and Clinical Use in Outpatient Settings
Michael H. A. Roehrl, M.D., Ph.D.
Director, UHN Program in BioSpecimen Sciences, Toronto,
Canada.
The Clinical Utility of the Immature Platelet Fraction
Alan D. Michelson, M.D.
Professor of Pediatrics and Professor of Medicine, Harvard
Medical School
Director, Center for Platelet Research Studies, Boston
Children’s Hospital/Dana-Farber Cancer Institute, Boston, MA
Mechanism of Thrombocytopenia in Chronic Hepatitis C
as Evaluated by the Immature Platelet Fraction
Marjorie L. Zucker, M.D.
Formerly Assoc. Professor of Pathology, Kansas University
Medical Center, Kansas City, KS
